Latest News & Updates
Breaking News
8 hours ago
Simantini Singh Deo
Other trending news you may like to read
Climb Bio Receives FDA Fast Track Designation For Budoprutug, An Investigational Anti-CD19 Antibody For Primary Membranous Nephropathy
Climb Bio secures FDA Fast Track designation for budoprutug, its anti-CD19 antibody for primary membranous nephropathy, supported by early clinical remission and safety data.
Simantini Singh Deo
Praxis Announces Positive EMBRAVE Trial Results Showing Significant Seizure Reduction With Elsunersen In Pediatric SCN2A Epilepsy
Praxis Precision Medicines, Inc. reports positive Phase 1/2 EMBRAVE trial results with elsunersen, showing significant seizure reduction in pediatric SCN2A epilepsy patients.
Vaibhavi M.
ImmunityBio Addresses FDA OPDP Concerns, Strengthens Compliance And Clarifies ANKTIVA Promotional Communications
ImmunityBio, Inc. addresses FDA OPDP concerns on ANKTIVA promotions, removes podcast content, and strengthens compliance measures to ensure accurate communication of approved indications.
Vaibhavi M.
Medicus Pharma Submits Optimised Phase 2 Trial Design For Teverelix To Address Unmet Need In BPH-Related Urinary Retention
Medicus Pharma Ltd. submits optimized Phase 2 trial design to FDA for Teverelix, targeting prevention of recurrent urinary retention in patients with benign prostatic hyperplasia.
Vaibhavi M.
